Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer
Clinical trial NCT07298538 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07298538
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-01
- Primary completion
- 2025-12-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.